Back to search

Article

The Impact of the Inflation Reduction Act on Investment in Innovative Medicines: A Project- Level Analysis

2024-12-17

Abstract excerpt

<title>Abstract</title> <p>The impact of Medicare’s price negotiation on long-term pharmaceutical innovation and patient welfare remains one of the most widely debated topics across stakeholder groups. Existing policy simulations have tried to assess the policy impacts on innovation based on either empirical estimates of elasticity of innovation from the literature or structural models estimating the joint distri...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
18e37ff4-6684-5138-9066-f0101115b2f4
DOI
10.21203/rs.3.rs-5434327/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Impact of the Inflation Reduction Act on Investment in Innovative Medicines: A Project- Level AnalysisDOI 10.21203/rs.3.rs-5434327/v1
Assessing the Value of Integrated Evidence Approaches in Drug DevelopmentSemantic proximity
Proposal for a Value-Based Agreement to Reimburse Anti-obesity Medicines in Traditional MedicareSemantic proximity
Pricing Treatments Cost-Effectively When They Have Multiple Indications: Not Just a Simple Threshold AnalysisSemantic proximity
The Net Financial Benefits of Single Vendor Integrated CDMO and CRO Drug Development ServicesSemantic proximity
Generative Mechanisms Influencing Economic Decision Making in Digital Therapeutics DevelopmentSemantic proximity
Financing translation: Analysis of the NCATS rare-diseases portfolioSemantic proximity
Methodological Challenges in Dutch HTA of Non-Oncological Orphan Drugs: A Retrospective Analysis and Price Comparison Using different Pricing ModelsSemantic proximity
Patients' Attitudes towards Switching to National Volume-Based Procurement (NVBP) Drugs -A Qualitative Investigation in Wuhan, ChinaSemantic proximity
Social and private value created through commercialization of Gilead Sciences’ innovative medicines for Hepatitis C and HIV: a cross-sectional analysisSemantic proximity
A Study on the Heterogeneous Effects of China’s Volume- Based Procurement on Gastrointestinal and Metabolic MedicationsSemantic proximity
Deregulation and pricing of medical services: A policy experiment based in ChinaSemantic proximity
How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access Ahead of Patent ExpirySemantic proximity
Select a neighboring publication to make it the new centre.